QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: jpet.108.150128v1 329/2/532    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by VanDeMark, K. L. Articles by Costa, L. G. Search for Related Content PubMed PubMed Citation Articles by VanDeMark, K. L. Articles by Costa, L. G.

NEUROPHARMACOLOGY

The Activation of M₁ Muscarinic Receptor Signaling Induces Neuronal Differentiation in Pyramidal Hippocampal Neurons

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington (K.L.V., M.G., G.G., L.G.C.); and Department of Human Anatomy, Pharmacology, and Forensic Sciences, University of Parma Medical School, Parma, Italy (L.G.C.)

Muscarinic receptors have been proposed to play an important role during brain development by regulating cell survival, proliferation, and differentiation. This study investigated the effect of muscarinic receptor activation on prenatal rat hippocampal pyramidal neuron differentiation and the signal transduction pathways involved in this effect. The cholinergic agonist carbachol, after 24 h in vitro, increased the length of the axon, without affecting the length of minor neurites. Carbachol-induced axonal growth was also observed in pyramidal neurons from the neocortex but not in granule neurons from the cerebellum. The effect of carbachol was mediated by the M₁ subtype of muscarinic receptors. The Ca²⁺ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, the two protein kinase C (PKC) inhibitors 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 2-{8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridol[1,2-a]indol-3-yl}-3-(1-methylindol-3-yl)maleimide (Ro-32-0432), and the extracellular signal-regulated kinase (ERK)1/2 inhibitors 2'-amino-3'-methoxyflavone (PD98059) and 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) all blocked carbachol-induced axonal outgrowth. In addition, down-regulation of ERK1/2 with small interfering RNA abolished the neuritogenic effect of carbachol. These data suggest an involvement of Ca²⁺, PKC, and ERK1/2 in carbachol-induced axonal growth. Carbachol indeed increased the release of Ca²⁺ from intracellular stores and induced PKC and ERK1/2 activation. Additional experiments showed that PKC, but not Ca²⁺, is involved in carbachol-induced ERK1/2 activation. Together, these results show that cholinergic stimulation of prenatal hippocampal pyramidal neurons accelerates axonal growth through the induction of Ca²⁺ mobilization and the activation of PKC and especially of ERK1/2.

Address correspondence to: Dr. Marina Guizzetti; Department of Environmental and Occupational Health Sciences, University of Washington, 4225 Roosevelt Way NE Suite 100, Seattle, WA 98105. E-mail: marinag{at}u.washington.edu